The production line increases efficiency by 40%, reduces energy
consumption by 22%, and delivers an annual output of 35,000 metric tons,
meeting 20% of global demand for high-end pharmaceutical foils. Pfizer
and Roche have completed factory audits, with initial orders allocated
for mRNA vaccine blister lid stock. The World Packaging Organization
(WPO) praised the technology for reducing defect rates from 0.3% to
0.005%, setting new GMP compliance benchmarks.
The FDA's 2024 Serialized Packaging Regulation mandates
intelligent production. A Boston Consulting Group report predicts the
global smart pharmaceutical packaging market will exceed $18 billion by
2027, with China capturing 35% due to industrial chain advantages. The
company plans to establish factories in Southeast Asia and Europe within
three years to strengthen global supply chain leadership.